Koran S et al.43 reported that CD117/c-kit expression in circulating tumor cells of advanced prostate cancer patients is associated with increased aggressiveness, decreased survival, and resistance to tyrosine kinase inhibitors by promoting cancer stem cell properties. The gene discussed is KIT; the disease is prostate carcinoma.